Literature DB >> 23388652

Consistency of symptom clusters among advanced cancer patients seen at an outpatient supportive care clinic in a tertiary cancer center.

Sriram Yennurajalingam1, Jung Hye Kwon1, Diana L Urbauer2, David Hui1, Cielito C Reyes-Gibby3, Eduardo Bruera1.   

Abstract

OBJECTIVE: Advanced cancer patients often develop severe physical and psychological symptom clusters (SCs), but limited data exist on their consistency or severity after an outpatient interdisciplinary team consultation led by palliative care specialists. The primary aim of the study was to determine the consistency and severity of SCs in advanced cancer patients in this setting.
METHOD: A total of 1373 patients with advanced cancer who were referred to The University of Texas MD Anderson Cancer Center's Outpatient Supportive Care Center between January 2003 and October 2008 with a complete Edmonton Symptom Assessment Scale (ESAS; 0-10 scale) occurred at initial and first follow-up visit were reviewed (median 14 days, range 1-4 weeks). We used a Wilcoxon signed-rank test to determine whether symptoms changed over time, and a principal components factor analysis with varimax rotation to determine SCs at baseline and at first follow-up. The number of factors calculated was determined based upon the number of eigenvalues.
RESULTS: The patients' ratings of the following symptoms (mean, SD) at the initial and follow-up visits, respectively, were: fatigue 6.2 (2.3) and 5.7 (2.5, p < 0.0001), pain 5.4 (2.9) and 4.6 (3, p < 0.0001), nausea 2.2 (2.8) and 2.0 (2.6, p < 0.0001), depression 3.0 (2.9) and 2.5 (2.7, p < 0.0001), anxiety 3.4 (3.0) and 2.8 (2.8, p < 0.0001), drowsiness 4.8 (3.1) and 4.4 (3.1, p < 0.0001), dyspnea 3.0 (2.9) and 2.7 (2.8), p < 0.0001), loss of appetite 4.2 (2.7) and 3.9 (2.7, p < 0.0001), sleep disturbances 4.2 (2.6) and 3.8 (2.6, P < 0.0001), and well-being 4.3 (2.5) and 3.9 (2.3, p < 0.0001). Cluster composition differentiated into physical (fatigue, pain, nausea, drowsiness, dyspnea, and loss of appetite) and psychological (anxiety and depression) components at the initial visit, and these two SCs were consistent upon follow-up. SIGNIFICANCE OF
RESULTS: We conclude that SCs remain constant between baseline and near-term follow-up but that the severity of those symptoms lessened during that interval. This knowledge may allow palliative care teams to provide more targeted and higher-quality care, but further studies are needed.

Entities:  

Mesh:

Year:  2013        PMID: 23388652     DOI: 10.1017/S1478951512000879

Source DB:  PubMed          Journal:  Palliat Support Care        ISSN: 1478-9515


  9 in total

Review 1.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

2.  An update in symptom clusters using the Edmonton Symptom Assessment System in a palliative radiotherapy clinic.

Authors:  Vithusha Ganesh; Liying Zhang; Stephanie Chan; Bo Angela Wan; Leah Drost; May Tsao; Cyril Danjoux; Elizabeth Barnes; Rachel McDonald; Leigha Rowbottom; Pearl Zaki; Ronald Chow; Matthew K Hwang; Carlo DeAngelis; Nicholas Lao; Edward Chow
Journal:  Support Care Cancer       Date:  2017-05-23       Impact factor: 3.603

3.  Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life.

Authors:  Sun Young Rha; Jiyeon Lee
Journal:  Support Care Cancer       Date:  2016-12-28       Impact factor: 3.603

Review 4.  Do Patients Benefit from a Trial of Corticosteroids at the End of Life?

Authors:  Sriram Yennurajalingam; Eduardo Bruera
Journal:  Curr Treat Options Oncol       Date:  2022-04-01

5.  Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report.

Authors:  Sriram Yennurajalingam; Janet L Williams; Gary Chisholm; Eduardo Bruera
Journal:  Oncologist       Date:  2016-02-17

6.  Association between prognostic awareness and quality of life in patients with advanced cancer.

Authors:  Karolina Vlckova; Kristyna Polakova; Anna Tuckova; Adam Houska; Martin Loucka
Journal:  Qual Life Res       Date:  2022-02-04       Impact factor: 4.147

7.  Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy.

Authors:  Kea Turner; Naomi C Brownstein; Zachary Thompson; Issam El Naqa; Yi Luo; Heather S L Jim; Dana E Rollison; Rachel Howard; Desmond Zeng; Stephen A Rosenberg; Bradford Perez; Andreas Saltos; Laura B Oswald; Brian D Gonzalez; Jessica Y Islam; Amir Alishahi Tabriz; Wenbin Zhang; Thomas J Dilling
Journal:  Radiother Oncol       Date:  2021-12-23       Impact factor: 6.280

8.  Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer.

Authors:  Wadih Rhondali; Gilles Freyer; Virginie Adam; Marilène Filbet; Martine Derzelle; Gaelle Abgrall-Barbry; Sophie Bourcelot; Jean-Louis Machavoine; Muriel Chomat-Neyraud; Olivier Gisserot; Rémi Largillier; Annick Le Rol; Frank Priou; Pierre Saltel; Claire Falandry
Journal:  Clin Interv Aging       Date:  2015-07-13       Impact factor: 4.458

Review 9.  Association of genetic polymorphisms with psychological symptoms in cancer: A systematic review.

Authors:  Sek Ying Chair; Bernard M H Law; Judy Y W Chan; Winnie K W So; Mary M Y Waye
Journal:  Asia Pac J Oncol Nurs       Date:  2021-12-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.